Literature DB >> 13678465

Neurocognitive performance and quality of life in patients with HIV infection.

Valerio Tozzi1, Pietro Balestra, Simonetta Galgani, Rita Murri, Rita Bellagamba, Pasquale Narciso, Andrea Antinori, Marinella Giulianelli, Gherardo Tosi, Marina Costa, Alessandro Sampaolesi, Massimo Fantoni, Pasquale Noto, Giuseppe Ippolito, Albert W Wu.   

Abstract

We examined the relationship of HIV-related cognitive impairment and health-related quality of life (QoL). Subjects were administered measures of cognitive function (a battery of 17 neuropsychological tests) and of QoL (the MOS-HIV questionnaire). Study measures also included comprehensive clinical and neurological evaluation, laboratory testing, and brain imaging studies in patients with impaired neuropsychological evaluation. One-hundred and eleven subjects were examined. Cognitively impaired patients (33.3%) reported poorer QoL scores in all domains (p < 0.05): physical health summary score (PHS) (44.6 vs. 49.9), mental health summary score (MHS) (37.7 vs. 44.4), pain (67.6 vs. 79.4), physical functioning (75.9 vs. 87.7), role functioning (32.4 vs. 41.5), social functioning (70.3 vs. 83.5), mental health (48.2 vs. 61.0), energy (53.1 vs. 63.0), health distress (60.8 vs. 75.5), cognitive functioning (CF) (60.5 vs. 71.8), general health perceptions (29.2 vs. 43.4), and QoL (36.5 vs. 47.0). The number of altered neuropsychological tests correlated significantly with MHS (p < 0.001), PHS (p < 0.03), CF (p < 0.02), and QoL (p < 0.02) scores. A correlation between seven of seven neuropsychological measures exploring speed of mental processing, three of four exploring mental flexibility, four of six exploring memory, and two of two exploring fine motor functioning and MHS, PHS, CF, or QoL scores was also found. Poor performance on the Digit Symbol test was most strongly associated with poor MHS (OR 1.04, 95% CI 1.01-1.08, p < 0.009) and PHS (OR 1.04, 95% CI 1.01-1.08, p < 0.01) scores, controlling for CD4 count, previous AIDS diagnosis, receiving HAART, and drug abuse. Cognitive impairment is associated with poor QoL. People with more severe cognitive impairment have the highest probability of having a poor QoL. Cognitive impairment in any cognitive domain explored in our battery is also associated with poor QoL. Poor performance on the Digit Symbol Test is the strongest predictor of poor QoL.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13678465     DOI: 10.1089/088922203322280856

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  61 in total

1.  The associations among coping, nadir CD4+ T-cell count, and non-HIV-related variables with health-related quality of life among an ambulatory HIV-positive patient population.

Authors:  Carl Armon; Kenneth Lichtenstein
Journal:  Qual Life Res       Date:  2011-09-22       Impact factor: 4.147

Review 2.  Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.

Authors:  Uraina S Clark; Ronald A Cohen
Journal:  Curr Opin Investig Drugs       Date:  2010-08

3.  Selective neurocognitive deficits and poor life functioning are associated with significant depressive symptoms in alcoholism-HIV infection comorbidity.

Authors:  Stephanie A Sassoon; Margaret J Rosenbloom; Rosemary Fama; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Psychiatry Res       Date:  2012-05-29       Impact factor: 3.222

4.  Extrapyramidal motor signs in older adults with HIV disease: frequency, 1-year course, and associations with activities of daily living and quality of life.

Authors:  Savanna M Tierney; Steven Paul Woods; David Sheppard; Ronald J Ellis
Journal:  J Neurovirol       Date:  2018-12-10       Impact factor: 2.643

5.  Regional cortical thinning associated with detectable levels of HIV DNA.

Authors:  Kalpana J Kallianpur; Gregory R Kirk; Napapon Sailasuta; Victor Valcour; Bruce Shiramizu; Beau K Nakamoto; Cecilia Shikuma
Journal:  Cereb Cortex       Date:  2011-10-19       Impact factor: 5.357

6.  Change in quality of life after being diagnosed with HIV: a multicenter longitudinal study.

Authors:  Joel Tsevat; Anthony C Leonard; Magdalena Szaflarski; Susan N Sherman; Sian Cotton; Joseph M Mrus; Judith Feinberg
Journal:  AIDS Patient Care STDS       Date:  2009-11       Impact factor: 5.078

Review 7.  Neurocognitive impact of antiretroviral treatment: thinking long-term.

Authors:  Megan E McPhail; Kevin R Robertson
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

8.  Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: preliminary results and suggestions for future study designs.

Authors:  Aminah Jatoi; Stephen P Kahanic; Stephen Frytak; Paul Schaefer; Robert L Foote; Jeff Sloan; Ronald C Petersen
Journal:  Support Care Cancer       Date:  2004-10-09       Impact factor: 3.603

9.  Growing older with HIV/AIDS: new public health challenges.

Authors:  Sean Cahill; Robert Valadéz
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

10.  Defining Plasma MicroRNAs Associated With Cognitive Impairment In HIV-Infected Patients.

Authors:  Ferdous Kadri; Andrea LaPlante; Mariacristina De Luca; Lisa Doyle; Cruz Velasco-Gonzalez; Jonathan R Patterson; Patricia E Molina; Steve Nelson; Arnold H Zea; Christopher H Parsons; Francesca Peruzzi
Journal:  J Cell Physiol       Date:  2016-04       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.